CDK4/6 inhibitors have potent activity in combination with pathway selective therapeutic agents in models of pancreatic cancer

Jorge Franco, Agnieszka K. Witkiewicz, Erik S. Knudsen

Research output: Contribution to journalArticlepeer-review

117 Scopus citations

Fingerprint

Dive into the research topics of 'CDK4/6 inhibitors have potent activity in combination with pathway selective therapeutic agents in models of pancreatic cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences